ARTICLE | Clinical News
Symbicort budesonide/formoterol: Phase III data
August 22, 2016 7:00 AM UTC
Top-line data from the 12-week, double-blind, international Phase III CHASE 3 trial in 279 patients ages 6-11 with asthma showed that Symbicort budesonide/formoterol in a pressurized metered dose inha...